A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics

PHASE2CompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 12, 2019

Study Completion Date

December 12, 2019

Conditions
Schizophrenia
Interventions
DRUG

Basmisanil

Participants received either 80 milligrams (mg) or 240 mg of Basmisanil, as per the dosing schedules described above.

DRUG

Placebo

Participants received matching Placebo to Basmisanil, as per the dosing schedules described above.

Trial Locations (37)

10035

Manhattan Psychiatric Center; Psychopharmacology Research Unit, New York

11516

Neurobehavioral Research, Inc., Cedarhurst

14618

Finger Lakes Clinical Research, Rochester

20877

CBH Health, Gaithersburg

30030

iResearch Atlanta, Decatur

32751

Meridien Research, Maitland

33136

University of Miami Dept of Psychiatry, Miami

33161

Behavioral Clinical Research, Inc., North Miami

33319

Innovative Clinical Research, Inc., Lauderhill

33770

Vantage Clinical Trials, Largo

44106

University Hospitals, Cleveland

44718

Neuro-Behavioral Clinical Research, Inc., Canton

45417

Midwest Clinical Research Center, Dayton

46060

Community Clinical Research Center, Anderson

60169

Alexian Brothers Center for Psychiatric Research, Hoffman Estates

63118

Arch Clinical Trials, LLC, St Louis

63141

St Louis Clinical Trials, St Louis

71115

Louisiana Clinical Research, LLC, Shreveport

72211

Woodland International Research Group Inc., Little Rock

72758

Woodland Research Northwest, LLC, Rogers

75042

Pillar Clinical Research LLC, Garland

75062

University Hills Clinical Research - Irving;Office of Dr. Knesevich, Irving

90230

ProScience Research Group, Culver City

90502

Collaborative Neuroscience Network Inc., Torrance

90660

CNRI - Los Angeles, LLC, Pico Rivera

90807

Alliance for Wellness, dba Alliance for Research, Long Beach

91206

California Clinical Trials, Glendale

91950

Synergy Clinical Research, National City

92103

Artemis Institute for Clinical Research, LLC, San Diego

92845

Collaborative Neuroscience Network, Inc., Garden Grove

92868

NRC Research Institute, Orange

94607

Pacific Research Partners, LLC, Oakland

98007

Northwest Clinical Research Center, Bellevue

06519

Yale School of Medicine - CT Mental Health Center (CMHC) - Schizophrenia Research Clinic, New Haven

71104-2136

Booker, J. Gary, MD, APMC, Shreveport

02114

Boston Medical Center, Boston

08009

Hassman Research Institute, Berlin

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02953639 - A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics | Biotech Hunter | Biotech Hunter